PCR-free shallow whole genome sequencing for chromosomal copy number detection from plasma of cancer patients is an efficient alternative to the conventional PCR-based approach.

[1]  D. M. Miedema,et al.  Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma. , 2020, Blood.

[2]  The Icgctcga Pan-Cancer Analysis of Whole Genomes Consortium.  Pan-cancer analysis of whole genomes , 2020 .

[3]  R. Chiu,et al.  The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB , 2020, American journal of human genetics.

[4]  D. Oepkes,et al.  TRIDENT-2: National Implementation of Genome-Wide Non-Invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. , 2019, American journal of human genetics.

[5]  F. Mouliere,et al.  Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA. , 2019, Cancer cell.

[6]  Ruud H. Brakenhoff,et al.  ACE: absolute copy number estimation from low-coverage whole-genome sequencing data , 2019, Bioinform..

[7]  G. Kazemier,et al.  Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review , 2019, JNCI cancer spectrum.

[8]  May M. Y. Liang-Chu,et al.  Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort , 2019, Clinical Cancer Research.

[9]  J. Vermeesch,et al.  Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  K. Curnow,et al.  Noninvasive Detection of Fetal Aneuploidy Using Next Generation Sequencing. , 2018, Methods in molecular biology.

[11]  M. Speicher,et al.  Current and future perspectives of liquid biopsies in genomics-driven oncology , 2018, Nature Reviews Genetics.

[12]  Keval Patel,et al.  Enhanced detection of circulating tumor DNA by fragment size analysis , 2018, Science Translational Medicine.

[13]  A. Cox,et al.  Genome-Wide Analysis of Circulating Cell-Free DNA Copy Number Detects Active Melanoma and Predicts Survival. , 2018, Clinical chemistry.

[14]  J. Sicklick,et al.  Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors , 2018, JAMA oncology.

[15]  M. Ebert,et al.  Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Savage,et al.  Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Nikhil Wagle,et al.  Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors , 2017, Nature Communications.

[18]  Winnie S. Liang,et al.  Evaluation of pre-analytical factors affecting plasma DNA analysis , 2017, bioRxiv.

[19]  James D. Brenton,et al.  Liquid biopsies come of age: towards implementation of circulating tumour DNA , 2017, Nature Reviews Cancer.

[20]  Y. Natkunam,et al.  PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Bauke Ylstra,et al.  Sequencing Structural Variants in Cancer for Precision Therapeutics. , 2016, Trends in genetics : TIG.

[22]  S. Farrington,et al.  A simple method to overcome the inhibitory effect of heparin on DNA amplification , 2015, Cellular Oncology.

[23]  P. Neven,et al.  Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. , 2015, JAMA oncology.

[24]  S. Linnarsson,et al.  Amplification-free sequencing of cell-free DNA for prenatal non-invasive diagnosis of chromosomal aberrations. , 2015, Genomics.

[25]  Sung-Bae Kim,et al.  Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. , 2015, The New England journal of medicine.

[26]  Pieter Wesseling,et al.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly , 2014, Genome research.

[27]  William A Weiss,et al.  Neuroblastoma and MYCN. , 2013, Cold Spring Harbor perspectives in medicine.

[28]  M. Haeusler,et al.  Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing , 2013, Genome Medicine.

[29]  D. Armbruster,et al.  Limit of blank, limit of detection and limit of quantitation. , 2008, The Clinical biochemist. Reviews.

[30]  Frank Speleman,et al.  Detection of DNA copy number alterations in cancer by array comparative genomic hybridization , 2007, Genetics in Medicine.

[31]  H. Parkes,et al.  Localised sequence regions possessing high melting temperatures prevent the amplification of a DNA mimic in competitive PCR. , 1998, Nucleic acids research.

[32]  J. I. Bell,et al.  Effect of heparin on polymerase chain reaction , 1994, The Lancet.

[33]  B. Ylstra,et al.  High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues. , 2012, Methods in molecular biology.